Sofinnova Partners Collaborates With NVIDIA to Accelerate European Life Sciences Startups

Contributed by: Business Wire

Logo

Tags

Technology

Medical Devices

Genetics

Health

General Health

Data Management

Other Science

Science

Artificial Intelligence

NVIDIA

More Like This

Sofinnova.AI (Photo: Sofinnova)

Sofinnova Partners Unveils Sofinnova.AI: A Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment Practice

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation

Edward Kliphuis, Partner, Sofinnova Digital Medicine Strategy and Simon Turner, Partner, Sofinnova Digital Medicine Strategy (Photo: Sofinnova Partners)

Sofinnova Partners Raises $200M Digital Medicine Fund

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support

Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups

Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France

Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments

Sofinnova Partners appoints Karl Naegler as Partner